These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza. Stepanova E; Isakova-Sivak I; Rudenko L Expert Rev Vaccines; 2022 Nov; 21(11):1533-1535. PubMed ID: 36004567 [No Abstract] [Full Text] [Related]
7. Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters. Zhang L; Jiang Y; He J; Chen J; Qi R; Yuan L; Shao T; Zhao H; Chen C; Chen Y; Wang X; Lei X; Gao Q; Zhuang C; Zhou M; Ma J; Liu W; Yang M; Fu R; Wu Y; Chen F; Xiong H; Nie M; Chen Y; Wu K; Fang M; Wang Y; Zheng Z; Huang S; Ge S; Cheng SC; Zhu H; Cheng T; Yuan Q; Wu T; Zhang J; Chen Y; Zhang T; Li C; Qi H; Guan Y; Xia N Nat Commun; 2023 Jul; 14(1):4117. PubMed ID: 37433761 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan. Sim JY; Wu PS; Cheng CF; Chao YC; Yu CH Emerg Infect Dis; 2022 Oct; 28(10):2126-2130. PubMed ID: 36037810 [TBL] [Abstract][Full Text] [Related]
9. Vaccine hesitancy among people with multiple sclerosis. Yap SM; Al Hinai M; Gaughan M; Callanan I; Kearney H; Tubridy N; McGuigan C Mult Scler Relat Disord; 2021 Nov; 56():103236. PubMed ID: 34507240 [TBL] [Abstract][Full Text] [Related]
10. Using Statewide Electronic Health Record and Influenza Vaccination Data to Plan and Prioritize COVID-19 Vaccine Outreach and Communications in Wisconsin Communities. Bonham-Werling J; DeLonay AJ; Stephenson K; Hendricks KA; Bednarz L; Weiss JM; Gigot M; Smith MA Am J Public Health; 2021 Dec; 111(12):2111-2114. PubMed ID: 34878860 [TBL] [Abstract][Full Text] [Related]
11. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection. Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551 [TBL] [Abstract][Full Text] [Related]
12. Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors. Doll MK; Pettigrew SM; Ma J; Verma A Clin Infect Dis; 2022 Aug; 75(1):e564-e571. PubMed ID: 35325923 [TBL] [Abstract][Full Text] [Related]
13. Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine. Zhao D; Chen X; Wang L; Zhang J; Zhao Z; Yue N; Zhu Y; Fei W; Li X; Tan L; He W Int J Biol Macromol; 2023 Apr; 234():123635. PubMed ID: 36801224 [TBL] [Abstract][Full Text] [Related]
14. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
16. Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity. Desikan R; Linderman SL; Davis C; Zarnitsyna VI; Ahmed H; Antia R Front Immunol; 2022; 13():985478. PubMed ID: 36263031 [TBL] [Abstract][Full Text] [Related]
17. Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study. Moscara L; Venerito V; Martinelli A; Di Lorenzo A; Toro F; Violante F; Tafuri S; Stefanizzi P Vaccine; 2023 Aug; 41(38):5655-5661. PubMed ID: 37544827 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 does not replicate in embryonated hen's eggs or in MDCK cell lines. Barr IG; Rynehart C; Whitney P; Druce J Euro Surveill; 2020 Jun; 25(25):. PubMed ID: 32613937 [TBL] [Abstract][Full Text] [Related]
19. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602 [TBL] [Abstract][Full Text] [Related]
20. Real-World Effectiveness of SARS-CoV-2 Vaccine Booster in Hemodialysis Patients with COVID-19 Receiving Molnupiravir. Chen PC; Huang CC; Fu CM; Chang YC; Wu PJ; Lee WC; Lee CT; Tsai KF Viruses; 2023 Feb; 15(2):. PubMed ID: 36851757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]